Is the MARS questionnaire a reliable measure of medication adherence in childhood asthma?

Patricia W Garcia-Marcos1,2, Paul L P Brand2,3, Adrian A Kaptein4

  • 1a Deparment of General Pediatrics, Arrixaca University Children's Hospital , University of Murcia , Murcia , Spain.

Insights

The Medication Adherence Report Scale (MARS-5) shows poor accuracy for measuring medication adherence in children with asthma. This self-report tool is unreliable for both clinical practice and research settings.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacy
  • Health Outcomes Research

Background:

  • Medication adherence is crucial for managing persistent asthma in children.
  • Accurate assessment tools are needed for clinical practice and research.
  • The Medication Adherence Report Scale (MARS-5) is a self-report measure for adherence.

Purpose of the Study:

  • To evaluate the reliability of the Medication Adherence Report Scale (MARS-5) for assessing adherence in children with persistent asthma.
  • To compare MARS-5 scores with electronically measured adherence rates.

Main Methods:

  • A prospective cohort study followed children (2-13 years) with persistent asthma for one year.
  • Electronically measured adherence to inhaled corticosteroids (ICS) was tracked.
  • Spearman's rank correlation and ROC curve analysis assessed the relationship between MARS-5 scores and electronic adherence.

Main Results:

  • High MARS-5 scores were reported (median 24).
  • A significant correlation existed between MARS-5 and electronic adherence (rho=0.47, p<0.0001), but with considerable variation.
  • The MARS-5 score of ≥23 had limited predictive ability (LR+ 1.65, LR- 0.27).

Conclusions:

  • The MARS-5 self-report scale is too inaccurate for reliable adherence assessment in pediatric asthma.
  • Findings suggest the MARS-5 is not a suitable tool for clinical practice or research in this population.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
970